InvestorsHub Logo
Followers 581
Posts 27164
Boards Moderated 1
Alias Born 03/18/2015

Re: Skiluc post# 47

Monday, 05/17/2021 6:54:17 PM

Monday, May 17, 2021 6:54:17 PM

Post# of 325
PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the Treatment of Parkinson’s Disease

https://www.otcmarkets.com/stock/PHRRF/news/story?e&id=1868621

Sometimes its Skil, Sometimes its Luc.

I’d rather have 1 genuine team follower then 100 look-a-likes.

Appreciate Member Marks!

ALL IMHO